Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-06

Clinical Trial Update: Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)

View source ↗

Summary

The ARCH clinical trial, led by Mayo Clinic, is evaluating whether hypothalamic amenorrhea can serve as a fertility-related marker for cardiovascular health; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Hypothalamic Amenorrhea | Status: ACTIVE_NOT_RECRUITING